Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CYT - Cyteir Therapeutics Inc

IEX Last Trade
2.725
0.005   0.183%

Share volume: 350,916
Last Updated: Tue 08 Aug 2023 09:54:55 PM CEST
Pharmaceutical Preparation Manufacturing : -2.88%

PREVIOUS CLOSE
CHG
CHG%
$2.72
0.01
0.18%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
57%
Profitability 68%
Dept financing 0%
Liquidity 0%
Performance 75%
Performance
5 Days
-0.37%
1 Month
-1.09%
3 Months
23.08%
6 Months
65.85%
1 Year
9.24%
2 Year
-86.07%
Key data
Stock price
$2.72
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$1.13 - $2.81
52 WEEK CHANGE
$0.05
MARKET CAP 
96.832 M
YIELD 
N/A
SHARES OUTSTANDING 
35.600 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.01
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$336,715
AVERAGE 30 VOLUME 
$214,374
Company detail
CEO:
Region: US
Website: cyteir.com
Employees: 42
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing

through a unique cancer treatment approach, cyteir therapeutics is creating breakthrough solutions to the major challenges facing cancer researchers today. currently in development, is the answer to the oncology triumvirate: reducing side effects, reducing therapy resistance, inducing diseased cell self destruction.

Recent news